SUSQUEHANNA INTERNATIONAL GROUP, LLP - AVADEL PHARMACEUTICALS PLC ownership

AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 101 filers reported holding AVADEL PHARMACEUTICALS PLC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of AVADEL PHARMACEUTICALS PLC
ValueSharesWeighting
Q3 2023$3,977,860
-72.0%
386,200
-55.1%
0.00%
-50.0%
Q2 2023$14,183,891
+84.8%
860,673
+2.7%
0.00%0.0%
Q1 2023$7,675,860
+17.8%
837,976
-7.9%
0.00%0.0%
Q4 2022$6,514,956
+49.8%
909,910
+4.8%
0.00%
Q3 2022$4,349,000
+73.1%
867,969
-15.7%
0.00%
Q2 2022$2,512,000
-41.4%
1,029,300
+63.9%
0.00%
Q1 2022$4,288,000
-46.5%
627,871
-36.7%
0.00%
Q4 2021$8,010,000
-6.7%
991,316
+13.2%
0.00%
-100.0%
Q3 2021$8,584,000
+96.7%
876,014
+35.1%
0.00%
Q2 2021$4,364,000
+32.2%
648,312
+77.4%
0.00%
Q1 2021$3,302,000
-17.5%
365,376
-39.0%
0.00%
Q4 2020$4,002,000
+143.6%
599,222
+83.8%
0.00%
Q3 2020$1,643,000
-12.7%
325,937
+39.8%
0.00%
Q2 2020$1,883,000
-47.6%
233,100
-48.5%
0.00%
-100.0%
Q1 2020$3,595,000
-11.0%
452,700
-15.4%
0.00%0.0%
Q4 2019$4,039,000
+324.7%
535,014
+134.1%
0.00%
Q3 2019$951,000
+11.9%
228,539
-22.3%
0.00%
Q2 2019$850,000
+2079.5%
294,267
+987.4%
0.00%
Q1 2019$39,000
-72.1%
27,061
-50.1%
0.00%
Q4 2018$140,000
-66.8%
54,182
-43.6%
0.00%
Q3 2018$422,000
-46.6%
96,089
-25.4%
0.00%
Q2 2018$790,000
-25.0%
128,815
-10.9%
0.00%
Q1 2018$1,054,000
+95.9%
144,573
+120.5%
0.00%
Q4 2017$538,000
+95.6%
65,580
+151.1%
0.00%
Q3 2017$275,000
+109.9%
26,122
+93.5%
0.00%
Q1 2017$131,00013,5000.00%
Other shareholders
AVADEL PHARMACEUTICALS PLC shareholders Q3 2023
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 985,210$10,345,0006.10%
Broadfin Capital, LLC 3,568,122$37,465,0005.54%
JW Asset Management, LLC 444,439$4,667,0003.42%
ARMISTICE CAPITAL, LLC 1,688,000$17,724,0002.09%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,655,494$38,383,0001.73%
FALCON POINT CAPITAL, LLC 661,490$6,284,0000.91%
KNOTT DAVID M 158,555$1,665,0000.71%
Perceptive Advisors 3,098,010$32,530,0000.62%
Sio Capital Management, LLC 91,413$960,0000.50%
HEARTLAND ADVISORS INC 700,000$7,350,0000.48%
View complete list of AVADEL PHARMACEUTICALS PLC shareholders